Skip to Content

Abatacept

In the US, Abatacept (abatacept systemic) is a member of the following drug classes: antirheumatics, selective immunosuppressants and is used to treat Juvenile Idiopathic Arthritis, Psoriatic Arthritis and Rheumatoid Arthritis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA24

CAS registry number (Chemical Abstracts Service)

0332348-12-6

Chemical Formula

C3750-H5872-N982-O1154-S38

Molecular Weight

84395

Therapeutic Categories

Selective immunosuppressant

Disease-modifying antirheumatic drug, DMARD

Monoclonal antibody

Chemical Name

1-25-Oncostatin M (human precursor) fusion protein wit CTLA-4 (antigen)(human) fusion protein wit immunoglobulin G1 (human heavy chain fragment), bimoleucular (146 -> 146')-disulfide (WHO)

Foreign Names

  • Abataceptum (Latin)
  • Abatacept (German)
  • Abatacept (French)
  • Abatacept (Spanish)

Generic Names

Brand Names

  • Ohrencia
    Bristol-Myers Squibb, Mexico
  • Orencia
    Abeefe Bristol-Myers Squibb, Peru; BMS, Turkey; BMS Bristol-Myers Squibb, South Korea; Bristol Myers Squibb, Chile; Bristol Myers Squibb, Spain; Bristol Myers Squibb, Latvia; Bristol-M.S., Argentina; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Israel; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, South Africa; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Bristol-Myers Squibb Pharmaceuticals, Austria
  • Orenica
    Bristol-Myers Squibb, Iceland

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide